tenofovir has been researched along with Herpes Simplex Virus Infection in 6 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 6 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Baeten, JM; Campbell, TB; Celum, C; Cent, A; Donnell, D; Firnhaber, C; Grinsztejn, B; Hakim, J; Hong, T; Hosseinipour, MC; Kumarasamy, N; Lalloo, U; Morrow, R; Nyirenda, M; Riviere, C; Sanchez, J; Santos, B; Supparatpinyo, K | 1 |
Andrei, G; Gillemot, S; Snoeck, R; Topalis, D | 1 |
Feng, J; Hang, TJ; Jia, YY; Lu, CT; Song, Y; Sun, Y; Wang, S; Wen, AD; Yang, ZF; Zhao, JY | 1 |
Casapia, M; Glidden, DV; Grant, RM; Hoagland, B; Lama, JR; Liu, AY; Marcus, JL; Mayer, KH; McMahan, V; Montoya-Herrera, O | 1 |
Ceña-Diez, R; de la Mata, FJ; García-Broncano, P; Gómez, R; Maly, M; Muñoz-Fernández, MÁ; Vacas-Córdoba, E | 1 |
Kaul, R; Raboud, JM; Tan, DH; Walmsley, SL | 1 |
2 trial(s) available for tenofovir and Herpes Simplex Virus Infection
Article | Year |
---|---|
Herpes Simplex Virus Type 2 Acquisition Among HIV-1-Infected Adults Treated With Tenofovir Disoproxyl Fumarate as Part of Combination Antiretroviral Therapy: Results From the ACTG A5175 PEARLS Study.
Topics: Adolescent; Adult; Antiviral Agents; Female; Herpes Simplex; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; International Cooperation; Male; Medication Adherence; Middle Aged; Pre-Exposure Prophylaxis; Proportional Hazards Models; Seroconversion; Tenofovir; Young Adult | 2017 |
Impact on L-carnitine Homeostasis of Short-term Treatment with the Pivalate Prodrug Tenofovir Dipivoxil.
Topics: Adenine; Adult; Antiviral Agents; Carnitine; Dose-Response Relationship, Drug; Female; Hepatitis B; Herpes Simplex; Homeostasis; Humans; Male; Organophosphonates; Prodrugs; Tenofovir | 2013 |
4 other study(ies) available for tenofovir and Herpes Simplex Virus Infection
Article | Year |
---|---|
The Anti-Human Immunodeficiency Virus Drug Tenofovir, a Reverse Transcriptase Inhibitor, Also Targets the Herpes Simplex Virus DNA Polymerase.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Cells, Cultured; DNA Mutational Analysis; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Exodeoxyribonucleases; Foscarnet; Herpes Genitalis; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; Humans; Mutation, Missense; Organophosphonates; Pyrimidines; Reverse Transcriptase Inhibitors; Selection, Genetic; Sequence Analysis, DNA; Tenofovir; Viral Proteins | 2018 |
Daily oral emtricitabine/tenofovir preexposure prophylaxis and herpes simplex virus type 2 among men who have sex with men.
Topics: Adenine; Adolescent; Adult; Aged; Antiviral Agents; Chemoprevention; Deoxycytidine; Emtricitabine; Herpes Simplex; Herpesvirus 2, Human; Homosexuality, Male; Humans; Incidence; Male; Middle Aged; Organophosphonates; Prevalence; Risk Factors; Tenofovir; Young Adult | 2014 |
Prevention of vaginal and rectal herpes simplex virus type 2 transmission in mice: mechanism of antiviral action.
Topics: Acyclovir; Administration, Rectal; Animals; Anti-Infective Agents; Antiviral Agents; Chlorocebus aethiops; Dendrimers; Epithelial Cells; Female; Herpes Simplex; Herpesvirus 2, Human; Humans; Hydrogen-Ion Concentration; Male; Mice, Inbred BALB C; Models, Molecular; Polyelectrolytes; Polymers; Rectum; Silanes; Tenofovir; Vagina; Vero Cells; Viral Proteins | 2016 |
No impact of oral tenofovir disoproxil fumarate on herpes simplex virus shedding in HIV-infected adults.
Topics: Adenine; Adult; AIDS-Related Opportunistic Infections; Canada; Female; Herpes Simplex; Herpesvirus 1, Human; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; Organophosphonates; Tenofovir; Virus Shedding | 2011 |